Morrisville, N.C., June 20, 2019 — Clinipace, a global full-service contract research organization (CRO), will showcase Clarity Stack® clinical technology at the 2019 Drug Information Association (DIA) Annual Meeting. Clarity Stack is an innovative clinical and study data aggregation solution that provides an up-to-date perspective of trial progress with visual insights and a holistic view of study-related information.
“Most sponsors are using some level of eClinical technology to access data and make decisions on study progress and patient safety,” said Jason Monteleone, MBA, Clinipace CEO. “But those solutions often operate in silos. Clarity Stack integrates individual and cross trial data which supports dynamic decision-making with near-real-time information.”
A suite of specialized tools provides efficient data interoperability to support regulatory compliance, protect patient safety, and ease the burden of time-consuming, manual review of disparate data.
“With the ever-increasing cost of clinical trials, we need to put key information into the hands of researchers fast so that fully informed, critical decisions can be made quickly,” said Charlene Dark, senior vice president, global clinical analytics. “Our Clarity Stack platform provides researchers data and insights to expedite decisions anytime, anywhere — even from a mobile device.”
To support the technology’s growth, Clinipace has added Mark Gorton, vice president of IT and innovation, to its team. With more than 30 years of industry experience in data and analytics, Gorton will lead the further development of Clarity Stack technologies to support more cost-effective trials and better patient outcomes.
Clinipace will be conducting demonstrations of Clarity Stack technology in Booth 1605 at DIA, June 24–26, 2019.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. With personalized services and solutions, local regulatory expertise and therapeutic leadership, we overcome the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology, rare disease, and women’s health. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach.